Michael J. Santostefano

1.5k total citations
40 papers, 1.2k citations indexed

About

Michael J. Santostefano is a scholar working on Health, Toxicology and Mutagenesis, Cancer Research and Molecular Biology. According to data from OpenAlex, Michael J. Santostefano has authored 40 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Health, Toxicology and Mutagenesis, 19 papers in Cancer Research and 7 papers in Molecular Biology. Recurrent topics in Michael J. Santostefano's work include Toxic Organic Pollutants Impact (21 papers), Carcinogens and Genotoxicity Assessment (18 papers) and Effects and risks of endocrine disrupting chemicals (15 papers). Michael J. Santostefano is often cited by papers focused on Toxic Organic Pollutants Impact (21 papers), Carcinogens and Genotoxicity Assessment (18 papers) and Effects and risks of endocrine disrupting chemicals (15 papers). Michael J. Santostefano collaborates with scholars based in United States, United Kingdom and Italy. Michael J. Santostefano's co-authors include Stephen Safe, Venkatesh Krishnan, Linda S. Birnbaum, Xiahong Wang, V. Morrison, Vicki M. Richardson, Weston W. Porter, Michael D. Threadgill, Mark Merchant and David Gaddis Ross and has published in prestigious journals such as Molecular and Cellular Biology, Analytical Chemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Michael J. Santostefano

40 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael J. Santostefano United States 20 711 435 337 185 182 40 1.2k
Willy A. Solis United States 10 500 0.7× 281 0.6× 437 1.3× 69 0.4× 139 0.8× 14 1.1k
Ellen C. Henry United States 21 677 1.0× 391 0.9× 387 1.1× 93 0.5× 112 0.6× 31 1.3k
Jennifer Marlowe United States 13 477 0.7× 326 0.7× 486 1.4× 89 0.5× 87 0.5× 17 1.2k
David S. Riddick Canada 19 577 0.8× 377 0.9× 587 1.7× 218 1.2× 556 3.1× 54 1.8k
R. Bars France 25 386 0.5× 249 0.6× 550 1.6× 199 1.1× 432 2.4× 51 1.7k
Markus R. Probst United States 17 652 0.9× 524 1.2× 637 1.9× 172 0.9× 147 0.8× 20 1.6k
Shigeyuki Uno Japan 24 451 0.6× 484 1.1× 678 2.0× 170 0.9× 384 2.1× 43 1.8k
Scott R. Nagy United States 6 1.1k 1.6× 502 1.2× 580 1.7× 135 0.7× 184 1.0× 9 2.1k
Mikael Gillner Sweden 15 348 0.5× 211 0.5× 354 1.1× 249 1.3× 138 0.8× 23 1.1k
Stephen Safe United States 12 441 0.6× 209 0.5× 438 1.3× 523 2.8× 92 0.5× 13 1.2k

Countries citing papers authored by Michael J. Santostefano

Since Specialization
Citations

This map shows the geographic impact of Michael J. Santostefano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Santostefano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Santostefano more than expected).

Fields of papers citing papers by Michael J. Santostefano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Santostefano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Santostefano. The network helps show where Michael J. Santostefano may publish in the future.

Co-authorship network of co-authors of Michael J. Santostefano

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Santostefano. A scholar is included among the top collaborators of Michael J. Santostefano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Santostefano. Michael J. Santostefano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Santostefano, Michael J., Danuta J. Herzyk, Diana Montgomery, & Jayanthi Wolf. (2019). Nonclinical safety of tildrakizumab, a humanized anti–IL-23p19 monoclonal antibody, in nonhuman primates. Regulatory Toxicology and Pharmacology. 108. 104476–104476. 6 indexed citations
2.
Ravani, Pietro, Rossella Gaggi, Michael J. Santostefano, et al.. (2008). The challenge of diagnosing atheroembolic renal disease clinical features and prognostic factors. Circulation 116. Clinical Journal of the American Society of Nephrology. 3(2). 317–323. 10 indexed citations
3.
Santostefano, Michael J.. (1999). Dose-dependent localization of TCDD in isolated centrilobular and periportal hepatocytes. Toxicological Sciences. 52(1). 9–19. 32 indexed citations
4.
Santostefano, Michael J., Xiaofeng Wang, Vicki M. Richardson, et al.. (1998). A Pharmacodynamic Analysis of TCDD-Induced Cytochrome P450 Gene Expression in Multiple Tissues: Dose- and Time-Dependent Effects. Toxicology and Applied Pharmacology. 151(2). 294–310. 32 indexed citations
5.
Santostefano, Michael J., David Gaddis Ross, Üzen Savas, Colin R. Jefcoate, & Linda S. Birnbaum. (1997). Differential Time–Course and Dose–Response Relationships of TCDD-Induced CYP1B1, CYP1A1, and CYP1A2 Proteins in Rats. Biochemical and Biophysical Research Communications. 233(1). 20–24. 49 indexed citations
6.
Santostefano, Michael J., et al.. (1996). Substituted flavones as aryl hydrocarbon (Ah) receptor agonists and antagonists. Biochemical Pharmacology. 51(8). 1077–1087. 61 indexed citations
7.
Krishnan, Venkatesh, Weston W. Porter, Michael J. Santostefano, Xiahong Wang, & Stephen Safe. (1995). Molecular Mechanism of Inhibition of Estrogen-Induced Cathepsin D Gene Expression by 2,3,7,8-Tetrachlorodibenzo- p -Dioxin (TCDD) in MCF-7 Cells. Molecular and Cellular Biology. 15(12). 6710–6719. 172 indexed citations
9.
Pucci, Giulia, Massimo Martino, Fortunato Morabito, et al.. (1995). Thrombotic thrombocytopenic purpura: a rare late complication of allogeneic bone marrow transplantation.. PubMed. 79(4). 371–3. 3 indexed citations
10.
Steinberg, Michael A., et al.. (1995). Induction of Cyp1a-1 and Cyp1a-2 gene expression by a reconstituted mixture of polynuclear aromatic hydrocarbons in B6C3F1 mice. Chemico-Biological Interactions. 96(3). 207–221. 55 indexed citations
11.
Wang, Xiaofang, Jane S. Thomsen, Michael J. Santostefano, et al.. (1995). Comparative properties of the nuclear aryl hydrocarbon (Ah) receptor complex from several human cell lines. European Journal of Pharmacology Molecular Pharmacology. 293(3). 191–205. 35 indexed citations
12.
Xiao-hong, Wang, Jane S. Thomsen, Michael J. Santostefano, et al.. (1995). Comparative properties of the nuclear aryl hydrocarbon (Ah) receptor complex from several human cell lines. European Journal of Pharmacology Environmental Toxicology and Pharmacology. 293(3). 191–205. 24 indexed citations
13.
Santostefano, Michael J., et al.. (1994). Effect of Ligand Structure on Formation and DNA Binding Properties of the Transformed Rat Cytosolic Aryl Hydrocarbon Receptor. Chemical Research in Toxicology. 7(4). 544–550. 9 indexed citations
14.
Carvan, Michael J., Michael J. Santostefano, Stephen Safe, & David L. Busbee. (1994). CHARACTERIZATION OF A BOTTLENOSE DOLPHIN (TURSIOPS TRUNCATUS) KIDNEY EPITHELIAL CELL LINE. Marine Mammal Science. 10(1). 52–69. 22 indexed citations
15.
Liu, H., Michael J. Santostefano, & Stephen Safe. (1994). 2-Phenylphenanthridinone and Related Compounds: Aryl Hydrocarbon Receptor Agonists and Suicide Inactivators of P4501A1. Archives of Biochemistry and Biophysics. 313(2). 206–214. 7 indexed citations
16.
Santostefano, Michael J., Inna Goldfarb, Michael J. Myers, et al.. (1994). Aryl hydrocarbon (Ah) receptor-independent induction of Cypla2 gene expression by acenaphthylene and related compounds in B6C3F1 mice. Carcinogenesis. 15(12). 2835–2840. 45 indexed citations
17.
Rowlands, Craig, Venkatesh Krishnan, Xiaofang Wang, et al.. (1993). Characterization of the aryl hydrocarbon receptor and aryl hydrocarbon responsiveness in human ovarian carcinoma cell lines.. PubMed. 53(8). 1802–7. 11 indexed citations
18.
Wang, Xiaofang, Michael J. Santostefano, Yi Lu, & Stephen Safe. (1992). A comparison of the mouse versus human aryl hydrocarbon (Ah) receptor complex: Effects of proteolysis. Chemico-Biological Interactions. 85(1). 79–93. 3 indexed citations
19.
Merchant, Mark, V. Morrison, Michael J. Santostefano, & Stephen Safe. (1992). Mechanism of action of aryl hydrocarbon receptor antagonists: Inhibition of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced CYP1A1 gene expression. Archives of Biochemistry and Biophysics. 298(2). 389–394. 64 indexed citations
20.
Santostefano, Michael J., J. Piskorska-Pliszczynska, V. Morrison, & Stephen Safe. (1992). Effects of ligand structure on the in vitro transformation of the rat cytosolic aryl hydrocarbon receptor. Archives of Biochemistry and Biophysics. 297(1). 73–79. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026